Charles Schwab Investment Management »

Aclaris Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $458k 436k 1.05
2023-09-30 $3.2M 463k 6.85
2023-06-30 $4.6M 444k 10.37
2023-03-31 $3.3M 410k 8.09
2022-12-31 $6.5M 412k 15.75
2022-09-30 $6.3M 403k 15.74
2022-06-30 $2.2M 154k 13.96
2022-03-31 $2.3M 133k 17.25
2021-12-31 $1.9M 129k 14.54
2021-09-30 $2.3M 127k 18.00
2021-06-30 $1.9M 108k 17.56
2021-03-31 $398k 16k 25.21
2020-12-31 $133k 21k 6.49
2020-09-30 $53k 21k 2.58
2020-06-30 $34k 21k 1.66
2020-03-31 $89k 85k 1.05
2019-12-31 $161k 85k 1.90
2019-09-30 $92k 85k 1.09
2019-06-30 $452k 207k 2.19
2019-03-31 $1.0M 174k 5.99
2018-12-31 $1.5M 200k 7.39
2018-09-30 $1.9M 134k 14.52
2018-06-30 $2.4M 122k 19.98
2018-03-31 $2.2M 126k 17.52
2017-12-31 $3.0M 122k 24.66
2017-09-30 $2.4M 93k 25.81
2017-06-30 $1.7M 62k 27.14
2017-03-31 $1.3M 44k 29.82
2016-12-31 $1.1M 41k 27.14
2016-09-30 $629k 25k 25.64
2016-06-30 $439k 24k 18.51
2016-03-31 $320k 17k 18.98
2015-12-31 $447k 17k 27.00

More positions owned by Charles Schwab Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Home Depot (HD)
Alphabet Cap Stk Cl C (GOOG)
Merck & Co (MRK)
Chevron Corporation (CVX)
Abbvie (ABBV)
Tesla Motors (TSLA)
Cisco Systems (CSCO)
Coca-Cola Company (KO)

View all positions for Charles Schwab Investment Management

Top funds holding Aclaris Therapeutics

BML Capital Management
Citadel Advisors
Vanguard Group
Millennium Management
D. E. Shaw & Co
Tang Capital Management
GSA Capital Partners
Two Sigma Investments
Two Sigma Advisers
Monaco Asset Management SAM
Deutsche Bank Aktiengesellschaft
Jacobs Levy Equity Management
Samsara BioCapital
Goldman Sachs Group
Citigroup

View all funds holding Aclaris Therapeutics